Início › Linfoma de Burkitt › Missouri › Kansas City
Ensaios clínicos de Linfoma de Burkitt em Kansas City, MO
10 estudos para Linfoma de Burkitt estão buscando participantes em locais em Kansas City e arredores (num raio de aproximadamente 30 milhas). Abra um estudo para ver quem pode participar e como contatar a equipe.
Texto oficial do estudo (Inglês)
Recrutando participantes para um estudo? Destaque-o no topo desta página — $99 por 30 dias →
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
RecrutandoFase 2
- Children's Mercy Hospitals and Clinics, Kansas City
Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia
RecrutandoFase 3
- University of Kansas Hospital-Westwood Cancer Center, Westwood · a 5 mi de distância
Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia
RecrutandoFase 2
- University of Kansas Hospital-Westwood Cancer Center, Westwood · a 5 mi de distância
Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
RecrutandoFase 2
- Children's Mercy Hospitals and Clinics, Kansas City
Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
RecrutandoFase 1/2
- Children's Mercy Hospital ( Site 1024), Kansas City
A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
RecrutandoFase 2
- Children's Mercy Hospitals and Clinics, Kansas City
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
RecrutandoFase 3
- Children's Mercy Hospitals and Clinics, Kansas City
Testing the Safety of Anti-Cancer Drug, CX-5461 (Pidnarulex), in Treating Lymphoma With Specific Changes in the MYC Gene
RecrutandoFase 1/2
- University of Kansas Hospital-Westwood Cancer Center, Westwood · a 5 mi de distância
Evaluating the Safety and Efficacy of DuoCAR20.19.22-D95 in Adult Patients With Relapsed or Refractory B-cell Malignancies
RecrutandoFase 1
- University of Kansas Cancer Center, Westwood · a 5 mi de distância
The EndRAD Trial: Eliminating Total Body Irradiation (TBI) for NGS-MRD Negative Children, Adolescents, and Young Adults With B-ALL
RecrutandoFase 2
- Children's Mercy Hospital, Kansas City
Ensaios de Linfoma de Burkitt em outras cidades
- Houston, TX21 estudos
- Philadelphia, PA16 estudos
- Milwaukee, WI16 estudos
- Chicago, IL15 estudos
- Cincinnati, OH13 estudos
- New York City, NY13 estudos
- Atlanta, GA12 estudos
- Aurora, CO11 estudos
- Seattle, WA11 estudos
- Durham, NC10 estudos
- Boston, MA10 estudos
- Los Angeles, CA10 estudos
Outros estudos em Kansas City
- Câncer de Mama34 estudos
- Câncer de Pulmão de Não Pequenas Células31 estudos
- Insuficiência Cardíaca25 estudos
- Câncer (todos os tipos)21 estudos
- Câncer de Pulmão19 estudos
- Câncer Colorretal16 estudos
- Câncer Metastático15 estudos
- Leucemia Mieloide Aguda15 estudos
- Câncer de Próstata14 estudos
- Câncer de Ovário11 estudos
- Obesidade11 estudos
- Diabetes tipo 211 estudos
Fonte: ClinicalTrials.gov, dados obtidos em 6 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.